PRHSX (T Rowe Price Hlth Sci)
Net Asset Value: 47.15
1-Day Return:
-0.23 (-0.49%)
YTD Return as of 4/5/13:
14.39%
Classification: Health/Biotech Objective: Health/Biotech Open to New Investors: Yes
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
Total Returns (As of 4/05/2013)
More| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 14.39 | 27.89 | 20.95 | 14.85 | 14.99 |
| Classification | 14.95 | 22.65 | 15.66 | 12.19 | 11.14 |
| Index (S&P 500) | NA | NA | NA | NA | NA |
| % Rank in Class (1-best,100=worst) | 60 | 20 | 11 | 32 | 17 |
Fund Stats
More| Investment Objective: | Health/Biotech |
|---|---|
| Net Assets ($Mil) | 6,195.20 |
| Inception Date: | 12/29/95 |
| Manager Name, Tenure | Taymour R. Tamaddon, 2013 |
| Expense Ratio: | 0.82% |
|
Sales Charge:
Load Type:
|
No Load 0.00% 0.00% |
Top 10 Holdings (As of 9/30/12)
More| Company Name | Symbol | % Net Assets |
|---|---|---|
| Alexion Pharmaceuticals Inc Ord | ALXN | 7.39 |
| Catamaran Corp Ord | CTRX | 4.71 |
| T Rowe Price Prime Reserve Fund | NA | 4.24 |
| Gilead Sciences Inc Ord | GILD | 3.20 |
| Pharmacyclics Inc Ord | PCYC | 2.73 |
| Valeant Pharmaceuticals International Inc Ord | VRX | 2.72 |
| Unitedhealth Group Inc Ord | UNH | 2.18 |
| Regeneron Pharmaceuticals Inc Ord | REGN | 2.09 |
| Incyte Corp Ord | INCY | 1.78 |
| Covidien Plc Ord | COV | 1.58 |
| % of Total Holdings | 32.62 | |
